BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10671777)

  • 1. Current status of minimally invasive treatment options for localized prostate carcinoma.
    Beerlage HP; Thüroff S; Madersbacher S; Zlotta AR; Aus G; de Reijke TM; de la Rosette JJ
    Eur Urol; 2000 Jan; 37(1):2-13. PubMed ID: 10671777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative therapies for localized prostate cancer.
    Beerlage HP
    Curr Urol Rep; 2003 Jun; 4(3):216-20. PubMed ID: 12756085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for cryoablation of the prostate in the management of localized prostate carcinoma?
    Long JP
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):675-90. PubMed ID: 8773504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target ablation--image-guided therapy in prostate cancer.
    Marien A; Gill I; Ukimura O; Betrouni N; Villers A
    Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryosurgery for prostate cancer.
    Fahmy WE; Bissada NK
    Arch Androl; 2003; 49(5):397-407. PubMed ID: 12893518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
    Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
    Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryosurgery for prostate cancer: new technology and indications.
    Benoit RM; Cohen JK; Miller RJ
    Curr Urol Rep; 2000 May; 1(1):41-7. PubMed ID: 12084340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local control of prostate cancer by transrectal HIFU-therapy.
    Kiel HJ; Wieland WF; Rössler W
    Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
    Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
    BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive treatment for localized prostate cancer.
    Porres D; Pfister D; Heidenreich A
    Minerva Urol Nefrol; 2012 Dec; 64(4):245-53. PubMed ID: 23288211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report.
    Uchida T; Sanghvi NT; Gardner TA; Koch MO; Ishii D; Minei S; Satoh T; Hyodo T; Irie A; Baba S
    Urology; 2002 Mar; 59(3):394-8; discussion 398-9. PubMed ID: 11880077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
    Cohen JK; Miller RJ; Rooker GM; Shuman BA
    Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment by HIFU of prostate cancer: survey of literature and treatment indications].
    Rébillard X; Davin JL; Soulié M;
    Prog Urol; 2003 Dec; 13(6):1428-56. PubMed ID: 15000326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage treatment in prostate cancer: a clinical approach.
    Bjerklund Johansen TE; Witzsch U; Greene D
    Expert Rev Anticancer Ther; 2013 May; 13(5):613-23. PubMed ID: 23617352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.